CCL22 and CCR4 also play an important role in cancer growth and metastasis [17-21], thus many CCR4 receptor antagonists as well as an anti-CCR4 antibody are being developed in the pharmaceutical industry [31,32]. Here, CCR4 is linked to cancer.